Canada markets closed

Marker Therapeutics, Inc. (GX1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.6200-0.1000 (-2.69%)
At close: 08:14AM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-5,662
-8,237
-29,931
-41,879
-28,706
-
Depreciation & amortization
-
-
3,680
3,163
1,076
286.582
Stock based compensation
277.773
858.269
3,305
5,964
5,228
-
Change in working capital
856.11
2,847
-4,764
5,472
2,398
-
Other working capital
-14,389
-16,440
-26,972
-30,411
-29,288
-
Other non-cash items
-
-
-278.681
-
-
-
Net cash provided by operating activites
-14,389
-16,440
-26,972
-27,280
-20,035
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-4,945
-3,131
-9,253
-374.983
Net cash used for investing activites
18,777
18,664
-4,945
-3,131
-9,253
-
Cash flows from financing activities
Common stock issued
394.666
1,015
202.13
52,553
6,186
-
Common stock repurchased
-
-
-
-
-
0
Net cash used privided by (used for) financing activities
534.239
1,105
202.13
52,556
6,736
-
Net change in cash
4,922
3,329
-31,715
22,145
-22,552
-
Cash at beginning of period
6,401
11,782
43,497
21,352
43,904
-
Cash at end of period
11,323
15,111
11,782
43,497
21,352
-
Free Cash Flow
Operating Cash Flow
-14,389
-16,440
-26,972
-27,280
-20,035
-
Capital Expenditure
-
-
-4,945
-3,131
-9,253
-374.983
Free Cash Flow
-14,389
-16,440
-26,972
-30,411
-29,288
-